Northeast Financial Consultants Inc Zoetis Inc. Transaction History

Northeast Financial Consultants Inc

$2.34 Billion
Q4 2024

A detailed history of Northeast Financial Consultants Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 44,233 shares of ZTS stock, worth $7.13 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

44,233

Previous 44,175 0.13%

Holding current value

$7.13 Million

Previous $8.63 Million 16.5%

% of portfolio

0.31%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$162.24 - $194.42 $9,409 - $11,276	58 Added 0.13%	44,233 $7.21 Million
Q3 2024 Nov 15, 2024	BUY	$172.58 - $196.48 $3,279 - $3,733	19 Added 0.04%	44,175 $8.63 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $100,283 - $115,662	600 Added 1.38%	44,156 $7.68 Million
Q2 2023 Aug 08, 2023	BUY	$160.94 - $186.23 $183,954 - $212,860	1,143 Added 2.69%	43,556 $7.5 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $47,571 - $57,231	327 Added 0.78%	42,413 $7.06 Million
Q3 2022 Nov 15, 2022	SELL	$148.29 - $182.55 $87,935 - $108,252	-593 Reduced 1.39%	42,086 $6.24 Million
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $5,458 - $7,003	-35 Reduced 0.08%	42,679 $7.34 Million
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $8,525 - $10,999	47 Added 0.11%	42,714 $8.06 Million
Q2 2021 Aug 16, 2021	BUY	$155.9 - $187.99 $2.52 Million - $3.04 Million	16,175 Added 61.06%	42,667 $7.95 Million
Q1 2021 May 13, 2021	BUY	$144.0 - $169.39 $409,536 - $481,745	2,844 Added 12.03%	26,492 $4.17 Million
Q2 2020 Jul 30, 2020	BUY	$111.92 - $142.53 $414,551 - $527,931	3,704 Added 18.57%	23,648 $3.24 Million
Q1 2020 May 13, 2020	SELL	$92.66 - $144.94 $5,374 - $8,406	-58 Reduced 0.29%	19,944 $2.35 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $38,130 - $43,706	-328 Reduced 1.61%	20,002 $2.65 Million
Q2 2019 Aug 09, 2019	SELL	$97.98 - $114.28 $9,993 - $11,656	-102 Reduced 0.5%	20,330 $2.31 Million
Q1 2019 May 14, 2019	BUY	$81.56 - $100.67 $347,608 - $429,055	4,262 Added 26.36%	20,432 $2.06 Million
Q4 2018 Feb 12, 2019	BUY	$79.28 - $95.27 $873,269 - $1.05 Million	11,015 Added 213.68%	16,170 $1.38 Million
Q3 2018 Nov 08, 2018	SELL	$83.5 - $93.23 $677,686 - $756,654	-8,116 Reduced 61.16%	5,155 $471,000
Q2 2018 Jul 27, 2018	BUY	$79.9 - $89.2 $301,302 - $336,373	3,771 Added 39.69%	13,271 $1.13 Million
Q1 2018 Apr 19, 2018	SELL	$71.51 - $84.69 $3,289 - $3,895	-46 Reduced 0.48%	9,500 $793,000
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $2,909 - $3,348	46 Added 0.48%	9,546 $687,000
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $567,435 - $621,300	9,500	9,500 $606,000

Others Institutions Holding ZTS

# of Institutions

2,060

Shares Held

420M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $75.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Zoetis Inc. Transaction History